American National Bank & Trust Sells 5,191 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

American National Bank & Trust reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 17.9% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 23,810 shares of the healthcare conglomerate's stock after selling 5,191 shares during the quarter. UnitedHealth Group comprises about 1.4% of American National Bank & Trust's portfolio, making the stock its 24th biggest position. American National Bank & Trust's holdings in UnitedHealth Group were worth $12,470,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. NewSquare Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $28,000. Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $30,000. Finally, Promus Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $32,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

UNH has been the subject of a number of recent research reports. Piper Sandler decreased their price objective on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a report on Tuesday. Wells Fargo & Company reduced their target price on UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Oppenheimer decreased their price target on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research report on Wednesday, May 14th. Truist Financial reaffirmed a "buy" rating and set a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $428.43.

Insiders Place Their Bets

In related news, CEO Stephen J. Hemsley purchased 86,700 shares of the business's stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer now directly owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. This represents a 14.63% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the business's stock in a transaction that occurred on Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders have bought 109,408 shares of company stock worth $31,607,768. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Trading Down 1.1%

NYSE:UNH traded down $3.29 during mid-day trading on Tuesday, reaching $301.43. 12,704,993 shares of the company's stock traded hands, compared to its average volume of 6,860,993. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a 50 day moving average price of $426.60 and a 200-day moving average price of $490.74. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market capitalization of $273.44 billion, a price-to-earnings ratio of 19.45, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter last year, the company posted $6.91 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.